Article info

Download PDFPDF
Letter
BCR::ABL1 screening is not indicated in patients with splenomegaly without neutrophilia and/or basophilia

Authors

  1. Correspondence to Dr Stephen E Langabeer, Cancer Molecular Diagnostics, Saint James's Hospital, Dublin, D08 W9RT, Ireland; slangabeer{at}stjames.ie
View Full Text

Citation

Langabeer SE
BCR::ABL1 screening is not indicated in patients with splenomegaly without neutrophilia and/or basophilia

Publication history

  • Received February 28, 2023
  • Accepted March 16, 2023
  • First published March 23, 2023.
Online issue publication 
October 01, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.